Global Emerging Market Equities, Propitious Research

Wium Malan, CFA

Global Equity Analyst with 15+ years of experience as a Buy Side analyst covering companies in the Emerging and Developed markets.
Fundamental and Quantitative analysis on companies in the Internet, Telecommunication, Media, Technology, IT Services, Healthcare, Pharmaceutical and other Industrial sectors.
Idea generation focussed on Quality stocks, trading below their intrinsic Value, with sound Corporate Governance.

Global Emerging Market Equities

Tencent/Netease: Approval Rotation to Netease in Feb

Tencent/Netease: Netease Tops '23 League Table with Most Games Approved

Tencent/Netease: Game Approval Accelerates, but Not for Big Names

Independent, Fundamental Quantitative Research

Propitious Research

Fully independent, fundamental and quantitative equity research, focused on companies in the Telecommunication, Media, Technology, Internet and Healthcare sectors in the Global Emerging Markets. Idea generation focused on Quality stocks, trading below their intrinsic Value, with sound Corporate Governance.

Equity Bottom-Up

<ul>
<li>Despite a disappointing 4Q2023 earnings report, <a href="https://www.smartkarma.com/entities/netease-inc" target="_blank" data-smartkarma-citation="entities:29030:1" rel="noopener">NetEase (9999 HK)</a> remains firmly amid an earnings upgrade cycle.</li>
<li>With NetEase touching on being oversold, near-term momentum indicators are displaying bullish signals.</li>
<li>NetEase currently trades more than one standard deviation below its rolling 5-year historic average PE ratio.</li>
</ul>


Despite a disappointing 4Q2023 earnings report, NetEase (9999 HK) remains firmly amid an earnings upgrade cycle.
With NetEase touching on being oversold, near-term momentum indicators are displaying bullish signals.
NetEase currently trades more than one standard deviation below its rolling 5-year historic average PE ratio.


NetEase: Positive Technical Analysis Signals